Alanyl-Glutamine Dipeptide Attenuates Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice by Improving Gut Microbiota Dysbiosis

Non-alcoholic fatty liver disease (NAFLD) manifests as a persistent liver ailment marked by the excessive buildup of lipids within the hepatic organ accompanied by inflammatory responses and oxidative stress. Alanyl-glutamine (AG), a dipeptide comprising alanine and glutamine, is commonly employed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yigang, Ying, Hanglu, Shi, Jiayi, Li, Long, Zhao, Yufen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534574/
https://www.ncbi.nlm.nih.gov/pubmed/37764772
http://dx.doi.org/10.3390/nu15183988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534574/
https://www.ncbi.nlm.nih.gov/pubmed/37764772
http://dx.doi.org/10.3390/nu15183988

Ejemplares similares